| Jessica Marie Aldrich, MA, LMHC, CRC, CADC | |
|
607 8th St Sw Ste A, Altoona, IA 50009-2315 | |
| (515) 681-4721 | |
| (515) 850-3221 |
| Full Name | Jessica Marie Aldrich |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 607 8th St Sw Ste A, Altoona, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326405440 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (* (Not Available)) | Secondary |
| 101YM0800X | Counselor - Mental Health | 084740 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Marie Aldrich, MA, LMHC, CRC, CADC 607 8th St Sw Ste A, Altoona, IA 50009-2315 Ph: (515) 681-4721 | Jessica Marie Aldrich, MA, LMHC, CRC, CADC 607 8th St Sw Ste A, Altoona, IA 50009-2315 Ph: (515) 681-4721 |
News Archive
The American Thyroid Association will present the John B. Stanbury Thyroid Pathophysiology Medal to Kenneth D. Burman, M.D. at the ATA's 86th Annual Meeting, September 21-25, 2016, in Denver, Colorado.
SIMPLE Antibody(TM) Platform Delivers Unprecedented Choice of Ultra-Potent Functional Antibody Leads Against Challenging Soluble and Cell Surface Targets. - ARGX-109, a Fully Human mAb Targeting Autoimmune, Inflammation and Oncology Indications, Enters Preclinical Development in Less Than 12 Months From Start of Discovery.
The Wistar Institute is pleased to announce that the National Institutes of Health has awarded a nearly $23 million Martin Delaney Collaboratories for HIV Cure Research grant to the BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy, a consortium of top HIV researchers led by co-principal investigators Luis J. Montaner, D.V.M., D.Phil., director of the HIV-1 Immunopathogenesis Laboratory at The Wistar Institute Vaccine Center, and James L. Riley, Ph.D., research associate professor at the Perelman School of Medicine at the University of Pennsylvania.
AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.
› Verified 4 days ago
Mrs. Cara Sanders, MS, NCC, LMHC, CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 700 1st Ave S Ste C, Altoona, IA 50009 Phone: 515-418-3837 | |
Ms. Carla Rae Davis, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 607 8th St Sw, Suite C, Altoona, IA 50009 Phone: 515-967-9150 Fax: 515-957-8031 |